Delivery Order SPE2DB24D2205-SPE2DB25FDSZM

Award Date 10/22/24
Potential Completion Date 11/13/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is a delivery order for VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication. The contract has a firm fixed-price pricing type and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the drug VYNDAMAX 61 MG CAPSULE UD 30S. The $12,960.30 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on June 25, 2024, with a completion date of July 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,960.30 Firm Fixed Price contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a period of performance through May 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S. The $13,408.24 firm fixed-price contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $13,408.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product, with a period of performance through January 22, 2025. The contract is a firm-fixed-price Delivery Order and does not have a set-aside designation. In addition to this specific contract,...
This federal contract award, valued at $13,846.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product, with a period of performance through May 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $13,408.24, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $12,960.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication, to support military treatment facilities and other government healthcare providers. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,408.24, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S medical products. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDSZM
    Delivery Order

This federal contract award is for $12,960.30 and was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication, with a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 1/22/25, 12:53 AM